While the immune reset field is mainly focused on depleting pathogenic B cells, ai3Bio is applying its novel approach to ...
Sufferers of complex, chronic diseases like POTS and long COVID often spend years searching for relief. The longtime tech ...
In 1,647 Framingham adults, closer MIND diet adherence was linked to slower gray matter loss over about 12 years. See the foods, MRI data, and limitations. Virginia's new nursing home sanctions ...
Scientists found that five seemingly unrelated conditions, including long Covid, ME/CFS, and PTSD, may disrupt many of the same biological networks involved in immunity, metabolism, and cellular ...
A schematic overview illustrating how the immune microenvironment is involved in diseases across various systems, including respiratory, cardiovascular, and digestive systems. Targeting cellular ...
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape ...
The main type of hives associated with autoimmunity is chronic spontaneous urticaria (CSU), also known as chronic idiopathic urticaria. Scientists believe that around 50% of people with a CSU ...
Our immune system implements an array of strategies to combat threatening infections. White blood cells called cytotoxic T lymphocytes or "CD8 T cells" are soldiers of the immune system, serving as ...
Vitiligo is a chronic autoimmune disease that occurs when the immune system attacks and destroys melanocytes, the cells that produce skin pigment. The resulting white patches may be its most visible ...
University of Arizona researchers may have uncovered a connection between chronic pain and a somewhat uncommon immune condition, opening the door to future research on immune biomarkers for chronic ...
In 1,647 Framingham adults, closer MIND diet adherence was linked to slower gray matter loss over about 12 years. See the foods, MRI data, and limitations. Virginia's new nursing home sanctions ...
Roivant Sciences Ltd. ROIV announced that Immunovant Inc. IMVT plans to halt the development of IMVT-1402 as a treatment for cutaneous lupus erythematosus (CLE). The decision follows recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results